Oscar Health (OSCR) stock
NYSE
As of the Nov 17, 2026 close (U.S. Eastern)
Events and reference metrics · 1
- Market cap
- $7.82B
- As of Nov 17, 2026
- P/E
- 9.14x
- Trailing twelve months
- P/B
- 3.52x
- Latest reported equity
- P/S
- 0.45x
- Trailing twelve months
- ROE
- 38.5%
- Trailing twelve months
- Dividend yield
- Not available
- Latest fiscal-year dividends
Multiples use the price as of Nov 17, 2026 and may differ from the current price.
- Market cap
- $7.82B
- As of Nov 17, 2026
- P/E
- 9.14x
- Trailing twelve months
- P/B
- 3.52x
- Latest reported equity
- P/S
- 0.45x
- Trailing twelve months
- ROE
- 38.5%
- Trailing twelve months
- Dividend yield
- Not available
- Latest fiscal-year dividends
Multiples use the price as of Nov 17, 2026 and may differ from the current price.
Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.
Price date for the multiples · Nov 17, 2026 · Financial period · Trailing twelve months
P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock
P/E
9.14x
P/B
3.52x
P/S
0.45x
Earnings and dividend metrics▾
Earnings
EPS
—
Earnings per share
BPS
—
Book value per share
ROE
38.5%
Return on equity
- ROE — how much the company earned on shareholder equity over a year: 38.5%.
ⓘ What are these valuation metrics?▾
P/E = share price ÷ earnings per share (EPS)
P/B = share price ÷ book value per share (BPS)
P/S = share price ÷ sales per share
P/E shows how many times annual earnings per share the price is; not all earnings are paid to shareholders. P/B compares the price with net assets, and P/S with sales.
Higher or lower is not good or bad by itself. Typical levels differ by industry; read P/B alongside ROE and P/S alongside margins.
ChickenStock computes these from SEC financial filings: net income and revenue are summed over the latest four quarters, and equity is the latest reported balance.
A negative P/E means a net loss. Reference information only, not a recommendation to buy or sell.
Latest earnings
SEC filingsJul–Sep 2026(FY2026 Q3)
Revenue increased 72.1% from the same period a year earlier.
Key reported figures come first. Select one to see the same quarter across three years.
Revenue · same quarter, three years
Year-ago quarter $2.99B+72.1%
$2.42B
Jul–Sep '24
$2.99B
Jul–Sep '25
$5.14B
Jul–Sep '26
The next earnings date has not been confirmed yet.
ⓘ Notes on these figures▾
- Results for Jul–Sep 2026 are from the 10-Q submitted to SEC EDGAR on Nov 5, 2026.
- Earnings per share increased from a year earlier. The year-ago value was zero or negative, so no percentage change is shown.
- Revenue increased 72.1% from the same quarter a year earlier.
- Operating income increased from a year earlier. The year-ago value was zero or negative, so no percentage change is shown.
- Net income increased from a year earlier. The year-ago value was zero or negative, so no percentage change is shown.
Filed Nov 5, 2026 · 10-Q · SEC EDGAR
Reported results are from SEC EDGAR filings. Reference information only, not investment advice.
Insider transactions
Recent Form 4 filings grouped by person, date and transaction type.
- Cohen TomerDirector · Nov 13, 2026Grant or award3,565 shares · $0Avg. price $03,565 shares held after
- Larsen Eric JonDirector · Nov 13, 2026Grant or award3,565 shares · $0Avg. price $03,565 shares held after
- Taneja RajatDirector · Nov 13, 2026Grant or award3,565 shares · $0Avg. price $03,565 shares held after
- WITTMAN VANESSA AMESDirector · Sep 18, 2026Open-market sale25,000 shares · $806KAvg. price $32.24112,121 shares held after
- Thrive Partners II GP, LLCDirector · Sep 18, 2026Other19,030,851 shares · $0Avg. price $0
Show 8 price lots
- 1,323,589 shares × $0$0
- 4,855,810 shares × $0$0
- 164,218 shares × $0$0
- 6,268,097 shares × $0$0
- 75,520 shares × $0$0
- 1,323,589 shares × $0$0
- 4,855,810 shares × $0$0
- 164,218 shares × $0$0
- Kushner JoshuaCo-Founder and Vice Chairman · Sep 18, 2026Other19,030,851 shares · $0Avg. price $0
Show 8 price lots
- 6,268,097 shares × $0$0
- 75,520 shares × $0$0
- 1,323,589 shares × $0$0
- 4,855,810 shares × $0$0
- 164,218 shares × $0$0
- 1,323,589 shares × $0$0
- 4,855,810 shares × $0$0
- 164,218 shares × $0$0
- Schlosser MarioDirector · Sep 3, 2026Open-market sale31,422 shares · $988KAvg. price $31.45449,444 shares held after
- Blackley Richard ScottChief Financial Officer · Sep 3, 2026Open-market sale28,869 shares · $908KAvg. price $31.451,046,108 shares held after
- Liang JanetPresident, Oscar Insurance · Sep 3, 2026Open-market sale10,360 shares · $326KAvg. price $31.45248,697 shares held after
- McAnaney AdamChief Legal Officer · Sep 3, 2026Open-market sale9,092 shares · $286KAvg. price $31.45209,004 shares held after
- Baltrus VictoriaChief Accounting Officer · Sep 3, 2026Open-market sale958 shares · $30KAvg. price $31.45213,631 shares held after
- Schlosser MarioDirector · Aug 28, 2026Open-market sale150,000 shares · $4.6MAvg. price $30.79480,866 shares held after
- Schlosser MarioDirector · Aug 28, 2026Conversion150,000 shares630,866 shares held after
- Schlosser MarioDirector · Aug 27, 2026Open-market sale600,000 shares · $18.2MAvg. price $30.34480,866 shares held after
- Schlosser MarioDirector · Aug 27, 2026Conversion600,000 shares1,080,866 shares held after
- Blackley Richard ScottChief Financial Officer · Aug 18, 2026Open-market sale18,750 shares · $595KAvg. price $31.7456,250 shares held after
Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.
Recent SEC filings
40 filingsFilings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.
Company overview
Expand ▾
Oscar Health (OSCR) stock information
NYSE
Oscar Health (OSCR) is listed on NYSE. Its market capitalization is about $7.8B. On trailing-twelve-month earnings the P/E ratio is 9.14, and the P/B ratio is 3.52. Return on equity is 38.5%. These figures are computed in-house from official filings and are reference information only.
Oscar Health — frequently asked questions
- What is the P/E ratio of Oscar Health (OSCR)?
- On a trailing-twelve-month basis, OSCR trades at a P/E ratio of 9.14. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
- What is the market capitalization of Oscar Health?
- OSCR has a market capitalization of about $7.8B. The figure moves with the share price and is refreshed each trading day.
- Is this page investment advice?
- No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.
All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.